Amoxicillin-clavulanate, commonly known by the veterinary brand name Clavamox or the human brand name Augmentin, is a combination antibiotic that pairs amoxicillin with clavulanic acid, a beta-lactamase inhibitor that extends the spectrum of bacterial coverage. Despite its widespread use and effectiveness in dogs, cats, and humans, this medication is absolutely contraindicated in guinea pigs and causes fatal enterotoxemia when administered to cavies. The combination of amoxicillin with clavulanic acid does nothing to reduce the danger to guinea pigs; the amoxicillin component remains just as lethal as when given alone. This page serves as an urgent warning to guinea pig owners about this commonly prescribed but fatally dangerous medication.
The mechanism of action of amoxicillin-clavulanate involves two components working together. Amoxicillin kills bacteria by interfering with cell wall synthesis, while clavulanic acid inhibits beta-lactamase enzymes that some bacteria produce to resist penicillin-type antibiotics. This combination makes the medication effective against a broader range of bacteria than amoxicillin alone. However, this enhanced antibacterial activity is precisely what makes it so dangerous to guinea pigs. The drug does not discriminate between pathogenic bacteria and the beneficial bacteria that guinea pigs require for survival, devastating the essential microbiome of the guinea pig's cecum and large intestine with fatal consequences.
Amoxicillin-clavulanate is available in numerous formulations designed for dogs, cats, and humans. Veterinary Clavamox comes in chewable tablets and palatable oral drops specifically formulated for pets. Human Augmentin is available in tablets, chewable tablets, and oral suspensions. All of these formulations are equally dangerous to guinea pigs regardless of the intended species or the delivery method. The pleasant flavors added to make these medications more palatable to dogs and children can make them particularly attractive and dangerous if a guinea pig were to encounter them accidentally. No formulation of amoxicillin-clavulanate is safe for guinea pigs under any circumstances.
The safety profile of amoxicillin-clavulanate in guinea pigs is entirely negative, with no therapeutic window or safe dosing range. Guinea pigs who receive this medication typically develop antibiotic-associated enterotoxemia within 24 to 72 hours, progressing rapidly from initial gastrointestinal disturbance to severe dysbiosis, toxin production, and death. The addition of clavulanic acid to amoxicillin does not protect guinea pig gut flora or reduce toxicity in any way. Exotic veterinarians universally recognize amoxicillin-clavulanate as contraindicated in guinea pigs, but general practice veterinarians who primarily treat dogs and cats may not be aware of this species-specific danger.
